Earnings Preview: Pfizer to Report Financial Results on April 29
Equities Fall Intraday as Investors Await Key Earnings, Macro Data
Pfizer (NYSE:PFE) Unveils Promising Preclinical Data On First-In-Class Oncology Drug
9 Health Care Stocks Whale Activity In Today's Session
Pfizer Q1 Earnings Preview: Wall Street Expects Y-o-y Declines in Both EPS and Revenue
Novavax Stock Is Up Again on Speculation Over the Fate of Its Covid Shot -- Barrons.com
Pfizer Call Volume Above Normal and Directionally Bullish
Today's Analyst Rating | Apple Price Target Raised to $235 by Morgan Stanley, HSBC Cuts Its Price Target Cut on Merck & Co to $100
Wells Fargo Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $28
HSBC Maintains Pfizer(PFE.US) With Buy Rating, Cuts Target Price to $27
Eli Lilly, Pfizer, Amgen – Trump's 25% Pharma Tariffs Could Drain $51B Annually
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE), Vertex Pharmaceuticals (VRTX) and Erasca (ERAS)
Analysts Sound Caution on Pfizer Stock (PFE) Ahead of Q1 Earnings
Pfizer's Potential Invasive Bladder Cancer Treatment Meets Primary Endpoint
Goldman Sachs: The Q1 performance of U.S. pharmaceutical stocks is reassuring, and the Industry sentiment is slightly becoming more positive.
Goldman Sachs stated that amid cautious sentiment from investors towards the USA pharmaceutical sector before the Earnings Reports season, the performance of USA pharmaceutical companies that have reported results so far for the first quarter has not been worse than expected, and in some cases, it has even exceeded expectations.
Will the US Stock Market's Rebound Ignite Your Next Trade?
Reported Saturday, Pfizer's Sasanlimab Combination Therapy Shows Strong Event-Free Survival Gains In High-Risk Non-Muscle Invasive Bladder Cancer
Pfizer (PFE) Reports Q1: Everything You Need To Know Ahead Of Earnings
Express News | Pfizer : HSBC Cuts Target Price to $27 From $35
Nona Biosciences' Partner Pfizer Presents Preclinical Data on TOP1i-Based ADC Targeting MSLN at AACR Annual Meeting 2025